Event Title

Autologous Islet Cell Transplantation-Future Forward Approach to Eliminating Long-Term Insulin Use

Presenter Information

Meghan Lahti, Nursing

Faculty Sponsor(s)

Jean Coffey

Abstract

A literature search was done with interest in a patient that I encountered during one of my clinical rotations. It is a future-forward robotic approach in hopes to reduce the use of life-long insulin therapy and pain management in patients with chronic pancreatitis. This procedure is called TPAIT (total pancreatectomy with autologous islet cell transplantation). Key words used in the research process included: islet cell, transplantation, chronic pancreatitis. The data bases used included: Academic Search Premier, Google Scholar, PubMed, and NCBI. Out of 8 studies, there was a total of 597 patients, with a 97% survival rate, 89.5% of patient’s pain had decreased, 97% had achievable islet cell function, and 57.25% had partial to full function of islet cells within the first 2-3 years.

Location

Hartman Union Building Courtroom

Start Date

5-2-2019 4:00 PM

End Date

5-2-2019 5:00 PM

This document is currently not available here.

Share

COinS
 
May 2nd, 4:00 PM May 2nd, 5:00 PM

Autologous Islet Cell Transplantation-Future Forward Approach to Eliminating Long-Term Insulin Use

Hartman Union Building Courtroom

A literature search was done with interest in a patient that I encountered during one of my clinical rotations. It is a future-forward robotic approach in hopes to reduce the use of life-long insulin therapy and pain management in patients with chronic pancreatitis. This procedure is called TPAIT (total pancreatectomy with autologous islet cell transplantation). Key words used in the research process included: islet cell, transplantation, chronic pancreatitis. The data bases used included: Academic Search Premier, Google Scholar, PubMed, and NCBI. Out of 8 studies, there was a total of 597 patients, with a 97% survival rate, 89.5% of patient’s pain had decreased, 97% had achievable islet cell function, and 57.25% had partial to full function of islet cells within the first 2-3 years.